Drugs / SR-exenatide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01156779 | Jul 2010 → Apr 2012 | diabetes mellitus | Dong-A Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SR-exenatide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01156779 ↗ |
| Route | Subcutaneous | “Subcutaneous Injection” NCT01156779 ↗ |